Transasia Bio-Medicals Appoints Aditi Pai as Group CFO

By: Women Entrepreneurs Review Team | Tuesday, 22 September 2026

Transasia Bio-Medicals Limited has appointed Aditi Pai as Group Chief Financial Officer, marking another step in her leadership journey with the company. Aditi joined Transasia in February 2024 and has progressed from Head of Finance to Chief Financial Officer and now Group Chief Financial Officer. She brings more than 15 years of experience in finance, accounting, financial control, corporate governance and business leadership.

Aditi served as Head of Finance at Transasia from February 2024 to March 2025 before being elevated to Chief Financial Officer in April 2025. In September 2026, she took on the role of Group Chief Financial Officer, expanding her responsibilities across the organization. Her career progression reflects her growing involvement in senior finance and broader business leadership.

Before joining Transasia, Aditi spent nearly four years at Bewakoof.com, where she served as Chief Financial Officer from May 2020 to January 2024. During her tenure, she also served as Business Head – COSMOS Beauty, gaining additional experience in business operations and leadership. Earlier, she worked as Finance Controller at Purplle.com, further building her experience in finance and consumer-focused digital businesses.

Key Highlights:

• Aditi has been appointed Group Chief Financial Officer at Transasia Bio-Medicals Limited
• She brings more than 15 years of experience in finance, accounting, governance and business leadership
• Aditi has held finance leadership roles at Bewakoof.com, Purplle.com, SNC-Lavalin and PwC

Aditi previously worked as Assistant Finance Controller and Company Secretary at SNC-Lavalin in Mumbai from 2016 to 2018. Her responsibilities across these finance leadership roles have contributed to experience spanning financial accounting, controllership, governance and broader corporate finance.

She began her professional journey with PwC, where she spent more than six years and progressed through roles including Article Assistant, Associate, Senior Associate and Assistant Manager. This foundation in professional services, followed by finance leadership positions across multiple industries, has shaped a career spanning more than 15 years. As Group Chief Financial Officer at Transasia Bio-Medicals Limited, Aditi now assumes broader financial leadership responsibilities across the organization.

Established in 1979 and headquartered in Mumbai, Transasia Bio-Medicals Limited is an in-vitro diagnostics company offering products and solutions across biochemistry, hematology, coagulation, ESR, immunology, urinalysis, critical care, diabetes management, microbiology and molecular diagnostics.

With more than four decades of experience in diagnostics, the company serves hospitals and laboratory chains with solutions designed to support accurate testing and patient care. Transasia operates as part of the Erba-Transasia Group and states that repeat customers account for approximately 60% of its sales.